Versant Capital Management’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2
| Closed | – | – | 1661 |
|
|
2021
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 1651 |
|
|
2020
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 1616 |
|
|
2020
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 1597 |
|
|
2020
Q2 | $0 | Sell |
2
-4
| -67% | -$149 | ﹤0.01% | 1658 |
|
|
2020
Q1 | $0 | Buy |
6
+4
| +200% | +$227 | ﹤0.01% | 1832 |
|
|
2019
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 1685 |
|
|
2019
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 1688 |
|
|
2019
Q2 | $0 | Sell |
2
-25
| -93% | -$1.76K | ﹤0.01% | 1826 |
|
|
2019
Q1 | $1K | Hold |
27
| – | – | ﹤0.01% | 1515 |
|
|
2018
Q4 | $2K | Hold |
27
| – | – | ﹤0.01% | 1309 |
|
|
2018
Q3 | $2K | Sell |
27
-21
| -44% | -$2K | ﹤0.01% | 1355 |
|
|
2018
Q2 | $4K | Hold |
48
| – | – | ﹤0.01% | 1179 |
|
|
2018
Q1 | $5K | Hold |
48
| – | – | ﹤0.01% | 1098 |
|
|
2017
Q4 | $4K | Sell |
48
-7
| -13% | -$697 | ﹤0.01% | 1208 |
|
|
2017
Q3 | $5K | Sell |
55
-10
| -15% | -$789 | ﹤0.01% | 1077 |
|
|
2017
Q2 | $5K | Hold |
65
| – | – | ﹤0.01% | 1077 |
|
|
2017
Q1 | $5K | Sell |
65
-23
| -26% | -$1.83K | ﹤0.01% | 1072 |
|
|
2016
Q4 | $6K | Hold |
88
| – | – | ﹤0.01% | 990 |
|
|
2016
Q3 | $6K | Buy |
88
+2
| +2% | +$145 | ﹤0.01% | 958 |
|
|
2016
Q2 | $5K | Hold |
86
| – | – | ﹤0.01% | 986 |
|
|
2016
Q1 | $6K | Sell |
86
-17
| -17% | -$1.07K | ﹤0.01% | 922 |
|
|
2015
Q4 | $6K | Buy |
+103
| New | +$6.28K | ﹤0.01% | 906 |
|
Versant Capital Management's CMD Position: Q2 2021 in Review
Versant Capital Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 2 shares.
Versant Capital Management first reported a position in CMD in Q4 2015 and held it in 22 quarters. The position peaked at $6K in Q4 2016. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Versant Capital Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Versant Capital Management sold 2 Cantel Medical Corporation shares in Q2 2021.
- Versant Capital Management first reported a position in Cantel Medical Corporation in Q4 2015 and held it in 22 quarters.
- Versant Capital Management's Cantel Medical Corporation position peaked at $6K in Q4 2016.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Versant Capital Management's 13F filing for Q2 2021, filed 22 Jul 2021.